» Bayer And Regeneron Dose First Patient In Second Phase 3 Study For <b>...</b>
has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. Additional…